| Income Statement | 2025-06-30 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| (loss) on warrant issuance | 0 | - | - | |
| Gain (loss) on investments | -9 | 273 | -85 | |
| Net loss | -2,794 | -3,700 | -1,836 | |
| Basic loss per share | -3.68 | -0.06 | -0.03 | |
| Diluted loss per share | -3.68 | -0.06 | -0.03 | |
| Weighted average shares outstanding basic | 759,289 | 57,677,016 | 52,837,477 | |
| Weighted average shares outstanding diluted | 759,289 | 57,677,016 | 52,837,477 | |
AIM ImmunoTech Inc. (AIM)
AIM ImmunoTech Inc. (AIM)